Skip to content

Clinical trials

Phase 4 Uterine Cervical Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 4 Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20061
20072
20093
20105
20111
20133
20151
20162
20171
20183
20201
20212
20221
20241
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status9
Not yet recruiting5
Recruiting5
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Merck Sharp & Dohme LLC2
Pfizer2
AGO Study Group1
Air Force Military Medical University, China1
Asan Medical Center1
Bital Savir-Baruch1
Boston Medical Center1
CHU de Reims1
Cancer Prevention and Research Institute, Italy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms39
Papillomavirus Infections7
Uterine Cervical Dysplasia5
Stomach Neoplasms4
Carcinoma, Hepatocellular3
Carcinoma, Non-Small-Cell Lung3
Endometrial Neoplasms3
Esophageal Neoplasms3
Ovarian Neoplasms3
Uterine Neoplasms3

Trials

Showing 51 to 39 of 39. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.